ESMO 2026

Alberto Giovanni Leone 周二在 #AACR26 分享了 INFINITY 试验的最新结果。该试验评估 tremelimumab 与 durvalumab 的联合治疗方案。在 AACR Annual Meeting News 中了解更多：https://t.co/bqUiZhEegV https://t.co/71VjEhfL1J

Clinical Trials Plenary: New Results from Immunotherapy Regimen Trials

Final Clinical Trials Plenary, 'Advances in Immunotherapy', chaired by Ryan Sullivan (Massachusetts General Hospital). Alberto Giovanni Leone (Istituto Nazionale dei Tumori) presented phase II INFINITY data on tremelimumab plus durvalumab for organ preservation in MSI-high tumours.

肝癌关注月专家播客：EMERALD-3 三期数据与肝胆肿瘤治疗策略更新

VJOncology 发布肝癌关注月专题播客，多位专家解读晚期肝细胞癌与肝胆肿瘤治疗进展。Ghassan Abou-Alfa 介绍 EMERALD-3 三期试验。